Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2024 ∙ Garai, R. Janosi, A. Krivacsy, P. Herczeg, V. Koi, T. Nagy, R. Imrei, M. Parniczky, A. Garami, M. Hegyi, P. Szabo, A. J.

Head-to-head comparison of influenza vaccines in children: a systematic review and meta-analysis

  • Children
  • Adolescents
  • Adults
  • Influenza
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Moderate
2024 ∙ Mitsikostas, D. D. Caronna, E. De Tommaso, M. Deligianni, C. I. Ekizoglu, E. Bolay, H. Göbel, C. H. Kristoffersen, E. S. Lampl, C. Moro, E. Pozo-Rosich, P. Sellner, J. Terwindt, G. Sieira, P. I.

Headaches and facial pain attributed to SARS-CoV-2 infection and vaccination: a systematic review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Bakare, D. Gobbo, E. Akinsola, K. O. Bakare, A. A. Salako, J. Hanson, C. Herzig van Wees, S. Falade, A. King, C.

Healthcare worker practices for HPV vaccine recommendation: A systematic review and meta-analysis

  • Healthcare workers
  • Human papillomavirus (HPV)
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Hobart, C. Pescarini, J. M. Evans, L. Adil, H. S. Adil, S. T. Deal, A. Carter, J. Matthews, P. C. Hargreaves, S. Clemente, N. S.

Hepatitis B infection and immunity in migrant children and pregnant persons in Europe: a systematic review and meta-analysis

  • Europe
  • Newborn
  • Children
  • Adolescents
  • Pregnant women
  • Hepatitis B
  • Coverage
  • Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Geta, M. Yizengaw, E. Manyazewal, T.

Hepatitis B vaccine effectiveness among vaccinated children in Africa: a systematic review and meta-analysis

  • Africa
  • Children
  • Hepatitis B
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Shah, S. Dahal, K. Thapa, S. Subedi, P. Paudel, B. S. Chand, S. Salem, A. Lammle, M. Sah, R. Krsak, M.

Herpes zoster vaccination and the risk of dementia: A systematic review and meta-analysis

  • All age groups
  • Herpes zoster
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Asante, M. A. Michelsen, M. E. Balakumar, M. M. Kumburegama, B. Sharifan, A. Thomsen, A. R. Korang, S. K. Gluud, C. Menon, S.

Heterologous versus homologous COVID-19 booster vaccinations for adults: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Administration
  • Safety
Methodological quality (AMSTAR 2):
Low
2024 ∙ Alpeza, F. Avermark, H. Gobbo, E. Herzig van Wees, S.

How has co-design been used to address vaccine hesitancy globally? A systematic review

  • All age groups
  • Human papillomavirus (HPV)
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Herieka, H. Babalis, D. Tzala, E. Budhathoki, S. Johnson, N. A.

How inclusive were UK-based randomised controlled trials of COVID-19 vaccines? A systematic review investigating enrolment of Black adults and adult ethnic minorities

  • Europe
  • United Kingdom
  • All age groups
  • COVID-19
  • Coverage
  • Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Li, C. Zhang, M. Karthijekan, K. Fu, X.

How nurses contribute to the elimination of hepatitis B? A systematic review and meta-analysis

  • Healthcare workers
  • Hepatitis B
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
Loading...